Ingredion Incorporated (INGR)
| Market Cap | 6.77B -19.0% |
| Revenue (ttm) | 7.20B -2.2% |
| Net Income | 674.00M +7.3% |
| EPS | 10.40 +9.9% |
| Shares Out | 63.00M |
| PE Ratio | 10.32 |
| Forward PE | 9.47 |
| Dividend | $3.28 (3.05%) |
| Ex-Dividend Date | Apr 1, 2026 |
| Volume | 701,002 |
| Open | 108.40 |
| Previous Close | 107.36 |
| Day's Range | 107.00 - 109.07 |
| 52-Week Range | 100.71 - 141.78 |
| Beta | 0.63 |
| Analysts | Buy |
| Price Target | 127.43 (+18.66%) |
| Earnings Date | May 5, 2026 |
About INGR
Ingredion Incorporated, together with its subsidiaries, engages in the manufacture and sale of sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries worldwide. The company operates in Texture & Healthful Solutions; Food & Industrial Ingredients–LATAM; and Food & Industrial Ingredients–U.S./CANADA segments. It offers starch products for use in a range of processed foods; cornstarch; specialty paper starches for enhanced draina... [Read more]
Financial Performance
In 2025, Ingredion's revenue was $7.22 billion, a decrease of -2.84% compared to the previous year's $7.43 billion. Earnings were $729.00 million, an increase of 12.67%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for INGR stock is "Buy." The 12-month stock price target is $127.43, which is an increase of 18.66% from the latest price.
News
Ingredion price target lowered to $114 from $122 at UBS
UBS analyst Joshua Spector lowered the firm’s price target on Ingredion (INGR) to $114 from $122 and keeps a Neutral rating on the shares.
Ingredion price target lowered to $120 from $128 at Barclays
Barclays analyst Benjamin Theurer lowered the firm’s price target on Ingredion (INGR) to $120 from $128 and keeps an Equal Weight rating on the shares.
Ingredion Earnings Call Transcript: Q1 2026
Q1 2026 saw a 1% sales decline and a 22% drop in adjusted operating income, mainly due to Argo facility issues and softer volumes in F&II U.S. Canada and LATAM. T&HS delivered its eighth straight quarter of volume growth, while full-year guidance was revised downward amid ongoing macro and FX headwinds.
Ingredion see Q2 revenue flat to up low single-digits
Q2 consensus $1.85B. For the second quarter of 2026, compared to the same quarter last year, the Company expects net sales to be flat to up low single-digits. Reported operating
Ingredion cuts FY26 adjusted EPS view to $10.45-$11.15 from $11.00-$11.80
FY26 consensus $11.33. This guidance reflects tariff levels in effect as of the end of April 2026. In addition, this guidance excludes any acquisition-related integration and restructuring costs, as w...
Ingredion reports Q1 adjusted EPS $2.34, consensus $2.47
Reports Q1 revenue $1.79B, consensus $1.79B. “While we expected a challenging first quarter after last year’s strong first quarter, results were weaker than anticipated in Food & Industrial Ingredient...
Ingredion Incorporated Reports First Quarter 2026 Results
First quarter 2026 reported and adjusted* operating income decreased 26% and 22% compared to the first quarter 2025 First quarter 2026 reported and adjusted EPS were $2.22 and $2.34, compared with $3....
Ingredion price target lowered to $126 from $130 at Oppenheimer
Oppenheimer analyst Kristen Owen lowered the firm’s price target on Ingredion (INGR) to $126 from $130 and keeps an Outperform rating on the shares. The firm adjusted targets in the
Ingredion to Release 2026 First Quarter Financial Results On May 5, 2026
WESTCHESTER, Ill., April 14, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, will release its first ...
Ingredion price target lowered to $122 from $124 at UBS
UBS lowered the firm’s price target on Ingredion (INGR) to $122 from $124 and keeps a Neutral rating on the shares.
Ingredion names Jason Payant as Interim CFO
In a regulatory filing, the company stated, “On March 18, 2026, the Board of Directors of Ingredion (INGR) elected Jason Payant to serve as Interim Chief Financial Officer of the
Ingredion Announces Retirement of Gregory B. Kenny, Director, and Names Siobhán Talbot to Board of Directors
WESTCHESTER, Ill., March 23, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions for food, beverage and industrial applications, today annou...
Ingredion Incorporated Declares Quarterly Dividend of $0.82 Per Share
WESTCHESTER, Ill., March 18, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions, announced today that its board of directors has declared a...
Ingredion, Shiru enter R&D collaboration for functional protein discovery
Shiru and Ingredion (INGR) announced a global R&D collaboration aimed at accelerating the discovery and commercialization of novel functional proteins for food, beverage, supplements and specialized n...
Ingredion and Shiru Announce Partnership to Accelerate AI-Powered Functional Protein Discovery
R&D collaboration combines Shiru's AI-discovery platform with Ingredion's global formulation expertise and scale to bring next-generation natural prebiotics to market faster R&D collaboration combines...
Ingredion Named One of the 2026 World's Most Ethical Companies®
Ingredion earns Ethisphere's 2026 World's Most Ethical Companies honor for the 12th time, recognizing its strong ethics, compliance and governance.
Benchmark starts Ingredion at Buy, sees ‘compelling entry point’
As previously reported, Benchmark analyst Ben Klieve initiated coverage of Ingredion (INGR) with a Buy rating and $130 price target Ingredion “sits at the intersection of health & wellness and
Ingredion initiated with a Buy at Benchmark
Benchmark initiated coverage of Ingredion (INGR) with a Buy rating and $130 price target
Ingredion management to meet with Oppenheimer
Meeting to be held on March 12 hosted by Oppenheimer.
Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada
Pharmaceutical manufacturers will benefit from deep expertise and an extensive distribution network paired with Ingredion's functional excipients DOWNERS GROVE, Ill., Feb. 24, 2026 /PRNewswire/ -- Uni...
Ingredion Transcript: Consumer Analyst Group of New York Conference (CAGNY) 2026
Record 2025 results were driven by innovation in texture, clean label, and private label solutions, with strong growth in LATAM and U.S./Canada. Strategic investments in AI, capacity, and productivity underpin a 2025-2028 outlook of mid-single digit OI growth and >10% TSR.
Ingredion appoints CEO Zallie as Chairman of Board
Ingredion (INGR) Incorporated announced that its board of directors has unanimously elected Jim Zallie, president and CEO, to assume the additional role of chairman of the board, effective immediately...
Ingredion Appoints President and CEO James P. Zallie as Chairman of the Board
WESTCHESTER, Ill., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions, today announced that its board of directors has unanimously...
Ingredion price target raised to $124 from $119 at UBS
UBS raised the firm’s price target on Ingredion (INGR) to $124 from $119 and keeps a Neutral rating on the shares.
Ingredion price target lowered to $120 from $123 at BMO Capital
BMO Capital analyst Andrew Strelzik lowered the firm’s price target on Ingredion (INGR) to $120 from $123 and keeps a Market Perform rating on the shares. The firm’s Q4 results